专利检索 ap:("CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD." OR "Lianyungang Runzhong Pharmaceutical Co., Ltd." OR "Shouyao Holdings (Beijing) Co., Ltd.") AND inv:"WANG, Zhao" 第 1 页

1.

发明公开
USE OF PYRROLOPYRIMIDINE COMPOUND FOR TREATING HEMOPHAGOCYTIC SYNDROME 审中-公开

公开(公告)号：EP4119562A1

公开(公告)日：2023-01-18

申请号：EP21767840.8

申请日：2021-03-09

申请人： CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. , Lianyungang Runzhong Pharmaceutical Co., Ltd. , Shouyao Holdings (Beijing) Co., Ltd.

发明人： LIANG, Hongming , ZHANG, Xiquan , WANG, Xunqiang , YU, Ding , WANG, Dong , GE, Qi , WANG, Zhao , WANG, Yini

IPC分类号： C07D487/04 , A61K31/519 , A61P7/00

摘要： The present invention relates to use of a pyrrolopyrimidine compound for treating hemophagocytic syndrome, and particularly relates to use of a compound of formula (I), a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition thereof for treating hemophagocytic syndrome.